General Newsroom Hero 1920x480 (4:1)
Our Work

Latham & Watkins Advises Odyssey Investment Partners in Acquisition of ProPharma Group

September 22, 2020
A multidisciplinary deal team led from the firm’s New York office is advising the private equity firm.

Odyssey Investment Partners (Odyssey) has announced that it has entered into an agreement to acquire ProPharma Group from Linden Capital Partners. Financial terms of the transaction were not disclosed.

Latham & Watkins LLP is advising Odyssey in the transaction with a corporate deal team led by New York partner John Giouroukakis and counsel Michael Vardanian, with associates Matthew Villar, Daniel Williams, and Sean McGrath. Advice was also provided on tax matters by New York partner Jocelyn Noll, with associate Amy Robertson; on employee benefits and compensation matters by New York partner Bradd Williamson, with associates Max Raskin and Charnae Supplee; on labor matters by Chicago counsel Nineveh Alkhas; on intellectual property matters by New York partner Jeffrey Tochner, with associate Caroline Herald; on healthcare matters by Washington, D.C. partners Stuart Kurlander and Ben Haas; on data privacy matters by Washington, D.C. counsel Marissa Boynton, with associate James Smith; on environmental matters by New York counsel David Langer; on antitrust matters by Washington, D.C. partner Jason Cruise and counsel Patrick English, with associate Doug Tifft; on insurance matters by Los Angeles partner Drew Levin, with associate Harrison White; and on finance matters by New York partners Joshua Tinkelman, Peter Sluka, and Stelios Saffos, with associates Melissa Fabian, Lena Dunn, Salvatore Vanchieri, and Egzon Sulejmani.


    Related Capabilities